Literature DB >> 29587142

Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity.

Purushothama Rao Tata1, Ryan D Chow2, Srinivas Vinod Saladi3, Aleksandra Tata4, Arvind Konkimalla5, Anne Bara4, Daniel Montoro6, Lida P Hariri7, Angela R Shih7, Mari Mino-Kenudson7, Hongmei Mou8, Shioko Kimura9, Leif W Ellisen3, Jayaraj Rajagopal10.   

Abstract

We show that the loss or gain of transcription factor programs that govern embryonic cell-fate specification is associated with a form of tumor plasticity characterized by the acquisition of alternative cell fates normally characteristic of adjacent organs. In human non-small cell lung cancers, downregulation of the lung lineage-specifying TF NKX2-1 is associated with tumors bearing features of various gut tissues. Loss of Nkx2-1 from murine alveolar, but not airway, epithelium results in conversion of lung cells to gastric-like cells. Superimposing oncogenic Kras activation enables further plasticity in both alveolar and airway epithelium, producing tumors that adopt midgut and hindgut fates. Conversely, coupling Nkx2-1 loss with foregut lineage-specifying SOX2 overexpression drives the formation of squamous cancers with features of esophageal differentiation. These findings demonstrate that elements of pathologic tumor plasticity mirror the normal developmental history of organs in that cancer cells acquire cell fates associated with developmentally related neighboring organs.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Waddington landscape; developmental history; non-small cell lung cancers; transdifferentiation; tumor heterogeneity; tumor plasticity

Mesh:

Substances:

Year:  2018        PMID: 29587142      PMCID: PMC5875457          DOI: 10.1016/j.devcel.2018.02.024

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   13.417


  50 in total

1.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

2.  Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.

Authors:  Yutaka Maeda; Tomoshi Tsuchiya; Haiping Hao; David H Tompkins; Yan Xu; Michael L Mucenski; Lingling Du; Angela R Keiser; Takuya Fukazawa; Yoshio Naomoto; Takeshi Nagayasu; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

Review 3.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Authors:  Piero Dalerba; Debashis Sahoo; Soonmyung Paik; Xiangqian Guo; Greg Yothers; Nan Song; Nate Wilcox-Fogel; Erna Forgó; Pradeep S Rajendran; Stephen P Miranda; Shigeo Hisamori; Jacqueline Hutchison; Tomer Kalisky; Dalong Qian; Norman Wolmark; George A Fisher; Matt van de Rijn; Michael F Clarke
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

Review 5.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

6.  Identification of Cis-regulatory elements in the mouse Pax9/Nkx2-9 genomic region: implication for evolutionary conserved synteny.

Authors:  Fabio Santagati; Kuniya Abe; Volker Schmidt; Thomas Schmitt-John; Misao Suzuki; Ken-Ichi Yamamura; Kenji Imai
Journal:  Genetics       Date:  2003-09       Impact factor: 4.562

Review 7.  Tracing the cellular origin of cancer.

Authors:  Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2013-01-20       Impact factor: 28.824

8.  Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity.

Authors:  Tae-Hee Kim; Fugen Li; Isabel Ferreiro-Neira; Li-Lun Ho; Annouck Luyten; Kodandaramireddy Nalapareddy; Henry Long; Michael Verzi; Ramesh A Shivdasani
Journal:  Nature       Date:  2014-01-12       Impact factor: 49.962

9.  SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.

Authors:  Giustina Ferone; Ji-Ying Song; Kate D Sutherland; Rajith Bhaskaran; Kim Monkhorst; Jan-Paul Lambooij; Natalie Proost; Gaetano Gargiulo; Anton Berns
Journal:  Cancer Cell       Date:  2016-10-10       Impact factor: 31.743

10.  SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.

Authors:  Bo Ram Kim; Emily Van de Laar; Michael Cabanero; Shintaro Tarumi; Stefan Hasenoeder; Dennis Wang; Carl Virtanen; Takaya Suzuki; Bizhan Bandarchi; Shingo Sakashita; Nhu An Pham; Sharon Lee; Shaf Keshavjee; Thomas K Waddell; Ming-Sound Tsao; Nadeem Moghal
Journal:  PLoS Biol       Date:  2016-11-23       Impact factor: 8.029

View more
  32 in total

1.  Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.

Authors:  Takashi Sato; Seungyeul Yoo; Ranran Kong; Abhilasha Sinha; Prashanth Chandramani-Shivalingappa; Ayushi Patel; Maya Fridrikh; Osamu Nagano; Takashi Masuko; Mary Beth Beasley; Charles A Powell; Jun Zhu; Hideo Watanabe
Journal:  Cancer Res       Date:  2019-09-24       Impact factor: 12.701

2.  The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.

Authors:  Gurkan Mollaoglu; Alex Jones; Sarah J Wait; Anandaroop Mukhopadhyay; Sangmin Jeong; Rahul Arya; Soledad A Camolotto; Timothy L Mosbruger; Chris J Stubben; Christopher J Conley; Arjun Bhutkar; Jeffery M Vahrenkamp; Kristofer C Berrett; Melissa H Cessna; Thomas E Lane; Benjamin L Witt; Mohamed E Salama; Jason Gertz; Kevin B Jones; Eric L Snyder; Trudy G Oliver
Journal:  Immunity       Date:  2018-10-16       Impact factor: 31.745

3.  WNT/RYK signaling restricts goblet cell differentiation during lung development and repair.

Authors:  Hyun-Taek Kim; Wenguang Yin; Yuko Nakamichi; Paolo Panza; Beate Grohmann; Carmen Buettner; Stefan Guenther; Clemens Ruppert; Yasuhiro Kobayashi; Andreas Guenther; Didier Y R Stainier
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

Review 4.  Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.

Authors:  Ryan C Smith; Viviane Tabar
Journal:  Cell Stem Cell       Date:  2018-12-20       Impact factor: 24.633

5.  Isl1 Regulation of Nkx2.1 in the Early Foregut Epithelium Is Required for Trachea-Esophageal Separation and Lung Lobation.

Authors:  Eugene Kim; Ming Jiang; Huachao Huang; Yongchun Zhang; Natalie Tjota; Xia Gao; Jacques Robert; Nikesha Gilmore; Lin Gan; Jianwen Que
Journal:  Dev Cell       Date:  2019-12-05       Impact factor: 12.270

6.  Development of solitary chemosensory cells in the distal lung after severe influenza injury.

Authors:  Chetan K Rane; Sergio R Jackson; Christopher F Pastore; Gan Zhao; Aaron I Weiner; Neil N Patel; De'Broski R Herbert; Noam A Cohen; Andrew E Vaughan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-25       Impact factor: 5.464

7.  Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1.

Authors:  Danielle R Little; Kamryn N Gerner-Mauro; Per Flodby; Edward D Crandall; Zea Borok; Haruhiko Akiyama; Shioko Kimura; Edwin J Ostrin; Jichao Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 8.  Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.

Authors:  Plabon Kumar Das; Suja Pillai; Md Abdur Rakib; Jahan Ara Khanam; Vinod Gopalan; Alfred K Y Lam; Farhadul Islam
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

9.  Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.

Authors:  Yi Liu; Ning Yin; Xue Wang; Andras Khoor; Vaishnavi Sambandam; Anwesha B Ghosh; Zoe A Fields; Nicole R Murray; Verline Justilien; Alan P Fields
Journal:  Cell Rep       Date:  2020-01-21       Impact factor: 9.423

10.  N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.

Authors:  Adeline Berger; Nicholas J Brady; Rohan Bareja; Brian Robinson; Vincenza Conteduca; Michael A Augello; Loredana Puca; Adnan Ahmed; Etienne Dardenne; Xiaodong Lu; Inah Hwang; Alyssa M Bagadion; Andrea Sboner; Olivier Elemento; Jihye Paik; Jindan Yu; Christopher E Barbieri; Noah Dephoure; Himisha Beltran; David S Rickman
Journal:  J Clin Invest       Date:  2019-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.